| Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017 | 2441 | 2017 |
| Final trial report of sentinel-node biopsy versus nodal observation in melanoma DL Morton, JF Thompson, AJ Cochran, N Mozzillo, OE Nieweg, DF Roses, ... New England Journal of Medicine 370 (7), 599-609, 2014 | 1704 | 2014 |
| Completion dissection or observation for sentinel-node metastasis in melanoma MB Faries, JF Thompson, AJ Cochran, RH Andtbacka, N Mozzillo, ... New England Journal of Medicine 376 (23), 2211-2222, 2017 | 1511 | 2017 |
| Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice … SL Wong, MB Faries, EB Kennedy, SS Agarwala, TJ Akhurst, C Ariyan, ... Journal of Clinical Oncology 36 (4), 399-413, 2018 | 453 | 2018 |
| Recent advances in the treatment of melanoma BD Curti, MB Faries New England Journal of Medicine 384 (23), 2229-2240, 2021 | 313 | 2021 |
| Systemic therapy for melanoma: ASCO guideline R Seth, H Messersmith, V Kaur, JM Kirkwood, R Kudchadkar, ... Journal of Clinical Oncology 38 (33), 3947-3970, 2020 | 278 | 2020 |
| Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+ T-Cell Function in Melanoma Patients I Bedrosian, R Mick, S Xu, H Nisenbaum, M Faries, P Zhang, PA Cohen, ... Journal of Clinical Oncology 21 (20), 3826-3835, 2003 | 252 | 2003 |
| The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I) MB Faries, JF Thompson, A Cochran, R Elashoff, EC Glass, N Mozzillo, ... Annals of surgical oncology 17, 3324-3329, 2010 | 242 | 2010 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 224 | 2019 |
| Incidence of sentinel node metastasis in patients with thin primary melanoma (# 1 mm) with vertical growth phase I Bedrosian, MB Faries, DP Guerry IV, R Elenitsas, L Schuchter, R Mick, ... Annals of surgical oncology 7, 262-267, 2000 | 215 | 2000 |
| An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma … DL Morton, N Mozzillo, JF Thompson, MC Kelley, M Faries, J Wagner, ... Journal of clinical oncology 25 (18_suppl), 8508-8508, 2007 | 214 | 2007 |
| Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I) JH Howard, JF Thompson, N Mozzillo, OE Nieweg, HJ Hoekstra, ... Annals of surgical oncology 19, 2547-2555, 2012 | 210 | 2012 |
| ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee U Keilholz, PA Ascierto, R Dummer, C Robert, P Lorigan, A Van Akkooi, ... Annals of oncology 31 (11), 1435-1448, 2020 | 206 | 2020 |
| Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study JS Weber, MS Carlino, A Khattak, T Meniawy, G Ansstas, MH Taylor, ... The Lancet 403 (10427), 632-644, 2024 | 196 | 2024 |
| Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine FF Amersi, AM Terando, Y Goto, RA Scolyer, JF Thompson, AN Tran, ... Clinical cancer research 14 (3), 638-645, 2008 | 188 | 2008 |
| Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12 … S Xu, GK Koski, M Faries, I Bedrosian, R Mick, M Maeurer, MA Cheever, ... The Journal of immunology 171 (5), 2251-2261, 2003 | 176 | 2003 |
| Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative … VK Sondak, DW King, JS Zager, S Schneebaum, J Kim, SPL Leong, ... Annals of surgical oncology 20, 680-688, 2013 | 174 | 2013 |
| Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? DM Iddings, AJ Fleisig, SL Chen, MB Faries, DL Morton Annals of surgical oncology 17, 40-44, 2010 | 165 | 2010 |
| Importance of sentinel lymph node biopsy in patients with thin melanoma BE Wright, RP Scheri, X Ye, MB Faries, RR Turner, R Essner, DL Morton Archives of Surgery 143 (9), 892-900, 2008 | 164 | 2008 |
| Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases MS Hughes, J Zager, M Faries, HR Alexander, RE Royal, B Wood, J Choi, ... Annals of surgical oncology 23, 1309-1319, 2016 | 159 | 2016 |
